Abnormal blood pressure regulation after orthostasis is a frequent symptom in Parkinson’s disease. Deficient noradrenaline excretion plays a major part in that respect. In an earlier study, we were able to show that r_-dopa (with a decarboxylase inhibitor) and selegiline had no significant effect on the noradrenaline excretion after active orthostasis [l]. In our subsequent study, we wanted to see to what extent dopamine agonists worked on heart rate, blood pressure decline, and noradrenaline excretion. We examined ten patients with idiopathic Parkinson’s disease (four women, six men, mean age 60.5 -f 9.25 yr). The patients were not selected according to such parameters as duration of illness, severity of symptoms or specific anti-parkinsonian medication. They were seen at a time of satisfactory drug management. The mean daily dose of the dopamine agonist bromocriptine was 8.5 ? 5.15 mg, the mean dose of Ldopa was 315 + 126.6 mg/day. Measurements were done after 10 min of rest (lying down) and after standing up in the first, third, fifth, seventh and ninth minutes. Testing was always carried out at the same time of the day (around 10 a.m.). Blood was taken via an indwelling cannula, which had been inserted into a vein of the forearm 30 min prior to the orthostatic test. Hormone concentrations of noradrenaline were determined by high performance liquid chromatography with electrochemical detection (HPLC-ECD). The drop in blood pressure was regular in only 3/ 10